Stock Events

Stock Events

Acarix AB 

0
0
+SEK0.00+0% 00:00 Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

5NovExpected
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
999
333
-333
-999
Expected EPS
N/A
Actual EPS
N/A

Financials

-653.32%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
7.36MRevenue
-48.09MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Edwards Lifesciences
EW
Mkt Cap51.82B
Edwards Lifesciences Corporation is known for its heart valve therapy products and critical care technologies, competing in the cardiovascular market.
Boston Scientific
BSX
Mkt Cap69.27B
Boston Scientific Corporation offers a wide range of medical devices including those for cardiovascular health, directly competing with Acarix AB's offerings.
Medtronic
MDT
Mkt Cap120.46B
Medtronic plc manufactures and sells device-based medical therapies, including those for cardiac and vascular diseases, competing in the same space as Acarix AB.
Intuitive Surgical
ISRG
Mkt Cap129.55B
Intuitive Surgical, Inc. provides robotic-assisted surgical technologies, indirectly competing by offering advanced medical devices in the same healthcare sectors.
Stryker
SYK
Mkt Cap116.27B
Stryker Corporation specializes in a variety of medical technologies, including those for surgical and cardiac applications, making it a competitor in the medical device field.
Zimmer Biomet
ZBH
Mkt Cap18.71B
Zimmer Biomet Holdings, Inc. focuses on musculoskeletal healthcare but its innovations in medical devices place it in indirect competition with Acarix AB.
Johnson & Johnson
JNJ
Mkt Cap663.28B
Johnson & Johnson engages in the production of healthcare products, including medical devices, competing broadly in the healthcare market.
Koninklijke Philips N.V.
PHG
Mkt Cap25.31B
Koninklijke Philips N.V. offers various health technology products and services, including those for cardiac care, competing in the same industry as Acarix AB.

About

Acarix AB (publ) operates as a medical technology enterprise, specializing in the development of swift, AI-powered diagnostic tools designed to exclude coronary artery disease (CAD). These solutions are deployed both within Sweden and on an international scale. The company's principal product is the CADScor System, an innovative diagnostic support device intended for immediate patient assessment. This system leverages precise acoustic measurements and sophisticated artificial intelligence algorithms to scrutinize blood flow within a patient's coronary arteries. Established in 2009, the firm maintains its corporate headquarters in Malmö, Sweden.
Show more...
CEO
Aamir Mahmood
Employees
8
Country
Sweden
ISIN
SE0017132400

Listings

ST
SE
ACARIX-BTA.ST
ST
SE
ACARIX-BT-UN.ST
F
DE
7AC.F
OTC Link
US
ACIXF

0 Comments

Share your thoughts

FAQ

What is Acarix AB stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Stockholm Exchange exchange Acarix AB stocks are traded under the ticker ACARIX-BTA.ST.
When is the next Acarix AB earnings date?▼
Acarix AB is going to release the next earnings report on November 05, 2026.
What is Acarix AB revenue for the last year?▼
Acarix AB revenue for the last year amounts to 7.36M SEK.
What is Acarix AB net income for the last year?▼
ACARIX-BTA.ST net income for the last year is -48.09M SEK.
How many employees does Acarix AB have?▼
As of September 08, 2026, the company has 8 employees.
In which sector is Acarix AB located?▼
Acarix AB operates in the Health & Wellness sector.
When did Acarix AB complete a stock split?▼
Acarix AB has not had any recent stock splits.
Where is Acarix AB headquartered?▼
Acarix AB is headquartered in Malmö, Sweden.